Record Information |
---|
Version | 1.0 |
---|
Creation date | 2015-10-09 22:30:49 UTC |
---|
Update date | 2017-01-19 02:36:25 UTC |
---|
FoodComEx ID | PC000464 |
---|
FoodDB Record | FDB022220 |
---|
Chemical Information |
---|
Name | L-3-Phenyllactic acid |
---|
Description | L-3-Phenyllactic acid (or PLA) is a chiral aromatic compound involved in phenylalanine metabolism. It is likely produced from phenylpyruvate via the action of lactate dehydrogenase. The D-form of this organic acid is typically derived from bacterial sources while the L-form is almost certainly endogenous. Levels of phenyllactate are normally very low in blood or urine. High levels of PLA in the urine or blood are often indicative of phenylketonuria (PKU) and hyperphenylalaninemia (HPA). PKU is due to lack of the enzyme phenylalanine hydroxylase (PAH), so that phenylalanine is converted not to tyrosine but to phenylpyruvic acid (a precursor of phenylactate). In particular, excessive phenylalanine is typically metabolized into phenylketones through, a transaminase pathway route involving glutamate. Metabolites of this transamination reaction include phenylacetate, phenylpyruvate and phenethylamine. In persons with PKU, dietary phenylalanine either accumulates in the body or some of it is converted to phenylpyruvic acid and then to phenyllactate through the action of lactate dehydrogenase. Individuals with PKU tend to excrete large quantities of phenylpyruvate, phenylacetate and phenyllactate, along with phenylalanine, in their urine. If untreated, mental retardation effects and microcephaly are evident by the first year along with other symptoms which include: unusual irritability, epileptic seizures and skin lesions. Hyperactivity, EEG abnormalities and seizures, and severe learning disabilities are major clinical problems later in life. A "musty or mousy" odor of skin, hair, sweat and urine (due to phenylacetate accumulation); and a tendency to hypopigmentation and eczema are also observed. The neural-development effects of PKU are primarily due to the disruption of neurotransmitter synthesis. In particular, phenylalanine is a large, neutral amino acid which moves across the blood-brain barrier (BBB) via the large neutral amino acid transporter (LNAAT). Excessive phenylalanine in the blood saturates the transporter. Thus, excessive levels of phenylalanine significantly decrease the levels of other LNAAs in the brain. But since these amino acids are required for protein and neurotransmitter synthesis, phenylalanine accumulation disrupts brain development, leading to mental retardation. [HMDB] |
---|
CAS Number | 20312-36-1 |
---|
Structure | |
---|
Synonyms | Synonym | Source |
---|
(-)-2-Hydroxy-3-phenylpropanoate | hmdb | (-)-2-Hydroxy-3-phenylpropanoic acid | hmdb | (-)-2-Hydroxy-3-phenylpropionate | hmdb | (-)-2-Hydroxy-3-phenylpropionic acid | hmdb | (-)-3-Phenyllactate | hmdb | (-)-3-Phenyllactic acid | hmdb | (-)-b-phenyllactate | hmdb | (-)-b-phenyllactic acid | hmdb | (-)-beta-phenyllactate | hmdb | (-)-beta-phenyllactic acid | hmdb | (2S)-2-hydroxy-3-phenylpropanoate | hmdb | (2S)-2-hydroxy-3-phenylpropanoic acid | hmdb | (2S)-2-Hydroxy-3-phenylpropionate | hmdb | (2S)-2-Hydroxy-3-phenylpropionic acid | hmdb | (R)-Phenyllactate | ChEBI | (R)-Phenyllactic acid | Generator | (S)-3-phenyl-Lactate | hmdb | (S)-3-phenyl-Lactic acid | hmdb | (S)-3-phenyllactic acid | hmdb | (s)-a-hydroxy-benzenepropanoate | hmdb | (s)-a-hydroxy-benzenepropanoic acid | hmdb | (s)-alpha-hydroxy-benzenepropanoate | hmdb | (s)-alpha-hydroxy-benzenepropanoic acid | hmdb | (s)-b-phenyllactic | hmdb | (s)-beta-phenyllactic | hmdb | Alpha-hydroxy-beta-phenyl-propionic acid | hmdb | D-3-Phenyllactate | Generator | D-3-Phenyllactic acid | ChEBI | HFA | hmdb | L-(-)-3-phenyllactic acid | hmdb | L-2-hydroxy-3-phenyl-propionic acid | hmdb | L-3-Phenyllactate | hmdb | L-beta-phenyllactic acid | hmdb | L-phenyl lactate | hmdb |
|
---|
Chemical Formula | C9H10O3 |
---|
IUPAC name | (2R)-2-hydroxy-3-phenylpropanoic acid |
---|
InChI Identifier | InChI=1S/C9H10O3/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8,10H,6H2,(H,11,12)/t8-/m1/s1 |
---|
InChI Key | VOXXWSYKYCBWHO-MRVPVSSYSA-N |
---|
Isomeric SMILES | O[C@H](CC1=CC=CC=C1)C(O)=O |
---|
Average Molecular Weight | 166.1739 |
---|
Monoisotopic Molecular Weight | 166.062994186 |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phenylpropanoic acids. Phenylpropanoic acids are compounds with a structure containing a benzene ring conjugated to a propanoic acid. |
---|
Kingdom | Organic compounds |
---|
Super Class | Phenylpropanoids and polyketides |
---|
Class | Phenylpropanoic acids |
---|
Sub Class | Not Available |
---|
Direct Parent | Phenylpropanoic acids |
---|
Alternative Parents | |
---|
Substituents | - 3-phenylpropanoic-acid
- Alpha-hydroxy acid
- Monocyclic benzene moiety
- Hydroxy acid
- Benzenoid
- Secondary alcohol
- Carboxylic acid derivative
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Organic oxygen compound
- Alcohol
- Carbonyl group
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Physico-Chemical Properties - Experimental |
---|
Property | Value | Reference |
---|
Experimental logP | Not Available | |
---|
Experimental Water Solubility | Not Available | |
---|
Melting Point | Not Available | |
---|
|
Foods of Origin |
---|
Food | Content Range | Average | Reference |
---|
Food | | | Reference |
---|
|
Production Data |
---|
Production Method | commercial |
---|
Production Method Reference | Not Available |
---|
Production Method Reference File | Not Available |
---|
Quantity Available | Production upon request, up to 200 mg |
---|
Delivery Time | Not Available |
---|
Storage Form | solid |
---|
Storage Conditions | -80°C |
---|
Stability | Not Available |
---|
Purity | Not Available |
---|
Spectra |
---|
Spectral Data Upon Request | Not Available |
---|
Provider Information |
---|
|
Commercial Vendors |
---|
Not Available |